Fadi Farhat - Concepedia

Author

Fadi Farhat

Also Known As

F Farhat, F. Farhat, F. S. Farhat, F.S. Farhat, Fadi Farhat, Fadi S Farhat, Fadi S. Farhat, Fadi Sami Farhat, Fajia Farhat, Farhat F

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Hôtel-Dieu de France Saint Joseph University Hammoud Hospital University Medical Center American University of Beirut Medical Center American University of Beirut

About

Fadi Farhat is an author at Hôtel-Dieu de France specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	340
2	Health Sciences	2	2	67
3	Engineering	1	1	58
4	Nursing	1	1	10
5	Biomedical Engineering	1	1	58

Fadi Farhat

Publications

762

Citations

H-Index

Page 1

	Year	Citations
Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study Joyce O’Shaughnessy, Susana Sousa, Josefina Cruz, European Journal of Cancer	2021	67
Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Yen‐Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy A. Azim, Journal of Clinical Oncology	2024	65
Desmoplastic small round cell tumors: results of a four-drug chemotherapy regimen in five adult patients Fadi Farhat, Stéphane Culine, Catherine Lhommé, Cancer	1996	64
FOLFOX-6 Combination as the First-Line Treatment of Locally Advanced and/or Metastatic Pancreatic Cancer Marwan Ghosn, Fadi Farhat, Joseph Kattan, American Journal of Clinical Oncology	2007	64
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial Philippe Merle, Jean‐Frédéric Blanc, Jean–Marc Phelip, The Lancet. Gastroenterology & hepatology NanoparticlesNanomedicineSorafenib Treatment FailureOncologyHepatology	2019	58
A Phase II Study of Lipoplatin (Liposomal Cisplatin)/Vinorelbine Combination in HER-2/neu–Negative Metastatic Breast Cancer Fadi Farhat, Sally Temraz, Joseph Kattan, Clinical Breast Cancer Liposomal CisplatinBreast OncologyOncologyMedicinePhase Ii Study	2011	46
Revealing a Cancer Diagnosis to Patients: Attitudes of Patients, Families, Friends, Nurses, and Physicians in Lebanon—Results of a Cross-Sectional Study Fadi Farhat, Areej Othman, G. el Baba, Current Oncology	2015	45
Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study Pieter W. Kamphuisen, A.Y.Y. Lee, Guy Meyer, Journal of Thrombosis and Haemostasis ThrombosisPulmonary EmbolismVenous ThrombosisVenous Disease TreatmentRelevant Bleeding	2018	37
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial Kathleen M. Mullane, Vicki A. Morrison, Luis H. Camacho, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentImmunologyVaccine Efficacy	2019	35
Gemcitabine plus Carboplatin Combination Therapy as Second-Line Treatment in Patients with Relapsed Breast Cancer Fady Nasr, G. Chahine, Joseph Kattan, Clinical Breast Cancer Second-line TreatmentCarboplatin Combination TherapyBreast OncologyRelapsed Breast CancerMedicine	2004	34

Page 1